Cortisol reactivity to a laboratory stressor predicts increases in depressive symptoms in perinatal and nulliparous women during population-level stress
Beech A, Edelman A, Yatziv T, Rutherford H, Joormann J, Gadassi-Polack R. Cortisol reactivity to a laboratory stressor predicts increases in depressive symptoms in perinatal and nulliparous women during population-level stress. Journal Of Affective Disorders 2023, 340: 33-41. PMID: 37499916, PMCID: PMC10529046, DOI: 10.1016/j.jad.2023.07.093.Peer-Reviewed Original ResearchMeSH KeywordsAdultBiomarkersCOVID-19DepressionFemaleHumansHydrocortisonePandemicsPregnancyStress, PsychologicalConceptsDepressive symptomsNulliparous womenCortisol reactivityLaboratory stressorHigh-risk groupDepressive symptom questionnairesBiomarkers of riskPsychosocial stress testCurrent depressive symptomsCOVID-19Salivary cortisol samplesPopulation-level stressorGestational weeksSymptom questionnairePerinatal periodNeed of interventionDepression riskCortisol levelsSymptomsCortisol samplesPregnancyWomenCOVID-19 pandemicStress testRisk